AMANDA PUCKETT: Open Payments
NPI 1114629037 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 19 payments from 5 companies in 2025. Trend: 2023 $940 · 2024 $399 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $267 |
| Supernus Pharmaceuticals, Inc. | 8 | $235 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: VRAYLAR, Qelbree, INGREZZA, TRINTELLIX, ABILIFY MAINTENA.
Industry payments across MD — which companies pay providers there.
